| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.8M | +22.1% |
| Cost of Revenue | $4.1M | +41.5% |
| Gross Profit | $4.6M | +8.8% |
| R&D Expense | $37.9M | +18.0% |
| SG&A Expense | $37.0M | +71.8% |
| Operating Income | -$80.5M | -35.5% |
| Pre-tax Income | -$82.7M | -60.5% |
| Net Income | -$82.7M | -60.5% |
| EPS (Basic) | -$0.60 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $1.7M | +118.2% |
| Inventory | $2.1M | -5.4% |
| Current Assets | $47.0M | +237.9% |
| Total Assets | $59.4M | +120.3% |
| Current Liabilities | $11.3M | -29.0% |
| Long-term Debt | $63.9M | +573.4% |
| Total Liabilities | $83.8M | +155.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$60.6M | -34.1% |
| Capital Expenditures | $583K | +37.8% |
| Investing Cash Flow | -$630K | -26.5% |
| Financing Cash Flow | $95.6M | +121.0% |
| Free Cash Flow | -$61.2M | -34.1% |
| -39.5% |
| EPS (Diluted) | -$0.60 | -39.5% |
| Stockholders' Equity |
| -$24.5M |
| -313.9% |